[1]赵辉,吴玉梅*.同步放化疗对卵巢移位术后的早期宫颈癌患者 性生活质量影响[J].中国计划生育和妇产科,2017,(12):49-52.
 ZHAO Hui,WU Yu-mei*.Effect of concurrent radiochemotherapy on quality of sexual life of early-stage cervical cancer patients after ovarian transposition[J].Chinese Journal of Family Planning & Gynecotokology,2017,(12):49-52.
点击复制

同步放化疗对卵巢移位术后的早期宫颈癌患者 性生活质量影响
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2017年12期
页码:
49-52
栏目:
论著与临床
出版日期:
2017-12-25

文章信息/Info

Title:
Effect of concurrent radiochemotherapy on quality of sexual life of early-stage cervical cancer patients after ovarian transposition
作者:
赵辉吴玉梅*
首都医科大学附属北京妇产医院妇科肿瘤科
Author(s):
ZHAO HuiWU Yu-mei*
Department of Gynecologic Oncology,Beijing Obstetrics and Gynecology Hospital, Capital Medical University,Beijing 100026,P.R.China
关键词:
子宫颈癌卵巢移位术性生活质量
Keywords:
cervical cancerovarian transpositionquality of sexual life
分类号:
R 73733
摘要:
目的探讨同步放化疗对宫颈癌根治术同时行卵巢移位的年轻早期宫颈癌患者性生活质量的影响。 方法对在首都医科大学附属北京妇产医院行宫颈癌根治术同时行卵巢移位手术的101例早期宫颈癌患者进行问卷调查,收集患者性生活质量评分,并分为术后补充同步放化疗(concurrent radiochemotherapy, CRT)组(34例)及未补充CRT组(67例)。对两组患者术后的激素水平、卵巢功能和生存质量进行比较。结果术后补充CRT组激素水平升高较术后未补充CRT组更为明显,差异有统计学意义(P<005)。早期宫颈癌根治术后未补充CRT组的患者性生活质量明显优于术后补充CRT组(P<005)。随着卵巢功能下降,这种趋势更为明显,但差异无统计学意义(P>005)。结论卵巢移位手术能保留部分卵巢功能,但并不能改善性生活质量。
Abstract:
ObjectiveThis study was designed to explore the impact of ovarian transposition(OT) during radical hysterectomy(RH) on patients’ quality of sexual life. Methods101 early-stage cervical cancer patients underwent OT during RH in Beijing Obstetrics and Gynecology Hospital were enrolled in the study and were divided into 2 groups: 34 patients underwent RH with OT and postoperative chemoradiotherapy(CRT) were included in the research group; 67 patients underwent RH with OT but without CRT were included in the control group. The postoperative hormone levels, ovarian function and quality of life were compared between the two groups. ResultsThe level of hormone in the research group was significantly higher than that of the control group after operation (P<005). The quality of sexual life of patients in the control group was significantly better than that of the research group(P<005). With the decline of ovarian function, this trend was more obvious, but the difference was not statistically significant . ConclusionOT can partially preserve ovarian function of patients undergo CRT after RH. However,CRT do lower the female sexual function.

参考文献/References:

[1]WHO. World Health Organization Report: Comprehensive Cervical Cancer Control: a guide of essential practice [R]: World Health Organization Web site(2014). [2]米颖,杨燕.腹腔镜卵巢移位手术对宫颈鳞癌患者放疗前作用研究 [J].国际医药卫生导报,2013,19(2):213-215. [3]吴小华,李子庭,黄啸.放疗对早期子宫颈癌患者移位卵巢功能的影响 [J].中华妇产科杂志,2005,40 (4):220-222. [4]王建六,张晓红,梁旭东.子宫颈癌患者卵巢腹腔内移位术后卵巢功能的评价 [J].中华妇产科杂志,2006,41(4):229-232. [5]Gubbala K,Laios A,Gallos I,et al. Outcomes of ovarian transposition in gynaecological cancers:a systematic review and meta-analysis [J].J Ovarian Res,2014,7:69-79. [6]MOAWAD N S, SANTAMARIA E, RHOTON-VLASAK A A. Laparoscopic ovarian transposition before pelvic cancer treatment: ovarian function and fertility preservation [J]. Journal of Minimally Invasive Gynecology, 2017, 24(1): 28-35. [7]URRUTIA M, ARAYA A, RIVERA S, et al. A predictive model for the quality of sexual life in hysterectomized women [J]. Revista Medica de Chile, 2007, 135(3): 317-325. [8]MOSSA B, SCHIMBERNI M, DI BENEDETTO L, et al. Ovarian transposition in young women and fertility sparing [J]. European Review for Medical and Pharmacological Sciences, 2015, 19(18): 3418-3425. [9]YOON A, LEE Y Y, PARK W, et al. Correlation between location of transposed ovary and function in cervical cancer patients who underwent radical hysterectomy [J]. Int J Gynecol Cancer, 2015, 25(4): 688-693. [10]SALIH S M, ALBAYRAK S, SEO S, et al. Diminished utilization of in vitro fertilization following ovarian transposition in cervical cancer patients [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2015, 60 (7/8): 345-353. [11]BLUMENFELD Z, EVRON A. Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists [J]. Expert Opinion on Pharmacotherapy, 2015, 16(7): 1009-1020. [12]LUISI S, ORLANDINI C, BILIOTTI G, et al. Hormone replacement therapy in menopause and in premature ovarian insufficiency [J]. Minerva Ginecologica, 2013, 65(6): 607-620.

相似文献/References:

[1]林文毅,李荣建,赖娜,等.15653例宫颈液基薄层细胞学检查回顾性分析[J].中国计划生育和妇产科,2010,(03):0.
[2]石一复,李娟清.人乳头状瘤病毒及其预防性疫苗的现况[J].中国计划生育和妇产科,2011,(02):0.
[3]梁志清.腹腔镜广泛子宫切除术泌尿系统并发症的预防与处理[J].中国计划生育和妇产科,2012,(01):0.
 LIANG Zhi-qing.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(12):0.
[4]姜志欣,蔡瑞芬,林宁,等.人群大样本子宫颈癌筛查中宫颈涂片的质量控制[J].中国计划生育和妇产科,2012,(01):0.
 JIANG Zhi-xin,CAI Rui-fen,LIN Ning,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(12):0.
[5]罗新,范瑾.hTERC基因检测技术在宫颈病变筛查中的地位[J].中国计划生育和妇产科,2013,(03):0.
 LUO Xin,FAN Jin.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[6]姜志欣,吴玉璘.女性人乳头瘤病毒感染及相关肿瘤[J].中国计划生育和妇产科,2014,(07):0.
[7]魏秀莉.大麻素受体2与子宫颈癌组织内浸润T细胞亚群的关系[J].中国计划生育和妇产科,2017,(9):70.
 WEI Xiu-li.The relationship between cannabinoid receptor 2 and infiltrating T-cell subsets in cervical cancer tissue[J].Chinese Journal of Family Planning & Gynecotokology,2017,(12):70.

备注/Memo

备注/Memo:
首都医科大学附属北京妇产医院青年基金专项(项目编号:fcyy201422)
更新日期/Last Update: 2017-12-25